Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
Faulkner E, Annemans L, Garrison L, Helfand M, Holtorf AP, Hornberger J, Hughes D, Li T, Malone D, Payne K, Siebert U, Towse A, Veenstra D, Watkins J; Personalized Medicine Development and Reimbursement Working Group. Faulkner E, et al. Among authors: annemans l. Value Health. 2012 Dec;15(8):1162-71. doi: 10.1016/j.jval.2012.05.006. Epub 2012 Sep 7. Value Health. 2012. PMID: 23244820 Free article.
Stratified medicine: a call for action.
Jacob I, Awada AH, Payne K, Annemans L. Jacob I, et al. Among authors: annemans l. Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):277-9. doi: 10.1586/erp.13.29. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 23763525 No abstract available.
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Jansen JP, et al. Among authors: annemans l. Value Health. 2011 Jun;14(4):417-28. doi: 10.1016/j.jval.2011.04.002. Value Health. 2011. PMID: 21669366 Free article.
Health economic evaluation of gene replacement therapies: methodological issues and recommendations.
Aballéa S, Thokagevistk K, Velikanova R, Simoens S, Annemans L, Antonanzas F, Auquier P, François C, Fricke FU, Malone D, Millier A, Persson U, Petrou S, Dabbous O, Postma M, Toumi M. Aballéa S, et al. Among authors: annemans l. J Mark Access Health Policy. 2020 Oct 11;8(1):1822666. doi: 10.1080/20016689.2020.1822666. J Mark Access Health Policy. 2020. PMID: 33144927 Free PMC article.
Pricing and reimbursement of pharmaceuticals in Belgium.
Annemans L, Crott R, De Clercq H, Huybrechts M, Peys F, Robays H, Steens I, Vanschoubroek K, Winderickx P. Annemans L, et al. Pharmacoeconomics. 1997 Mar;11(3):203-9. doi: 10.2165/00019053-199711030-00001. Pharmacoeconomics. 1997. PMID: 10165309
374 results